GSTM1 and hemoglobinopathy: The identified haemoglobinopathies included β-thalassaemia in 1,272 (81.38%), Hb variants in 175 (11.19%), and hereditary persistence of fetal haemoglobin (HPFH) in 116 (7.4%) of the patients.